Lianhuan pharmaceutical industry. Is a national large-scale comprehensive pharmaceutical enterprise established in 1958. 199965438+in February, with the approval of Jiangsu Provincial People's Government document Su 199 166, Yangzhou Pharmaceutical Factory was the main sponsor, together with Shanghai Lianchuang Investment Co., Ltd., Sinopharm Group Pharmaceutical Co., Ltd., Jiangsu Property Rights Management Co., Ltd. and Suzhou Industrial Park.
Lu Kang medicine. It is a large comprehensive chemical pharmaceutical enterprise in China and an important antibiotic production base in China. Lu Kang Pharmaceutical A-share (600789) was listed on Shanghai Stock Exchange in February, 1997. The total assets are 2.5 billion yuan, and there are more than 5,700 employees, and all kinds of professional and technical personnel account for 30%. Lu Kang's predecessor, Jining Antibiotic Factory, was established in 1966. 1984 was the first batch of factory director responsibility system in the whole province, and 1992 was transformed into the first large-scale joint-stock enterprise in Shandong pharmaceutical system. 1997 "Lu Kang pharmaceutical" a shares are listed on the Shanghai stock exchange. "Lu Kang Brand" is a well-known trademark in China and is listed as an internationally renowned brand in Shandong Province.
Rhine Biological Company is a joint-stock company established by the overall change of Rhine biological products. It was incorporated in Xing 'an, Guilin on October 28th, 2000/kloc-0. In June 5438+February, 2004, with the approval of Guangxi Zhuang Autonomous Region People's Government Gui Zheng Han [2004] No.212, Rheinland Biological Products was changed to Guilin Rheinland Biotechnology Co., Ltd., and was registered in Guangxi Zhuang Autonomous Region Administration for Industry and Commerce in June 65438+February, 2004, with the industrial and commercial registration number of (Enterprise) 45000066. Before this issuance, the registered capital of the company was 48,266,880 yuan, and the legal representative was Qin Benjun. The business scope is the production and sale of plant products (Ginkgo biloba, grape seeds, Siraitia grosvenorii, willow bark, etc.). ), agricultural and sideline products, and self-operated import and export.
Neptune Biological Neptune Biological, formerly known as Shenzhen Shekou Neptune Biological Engineering Co., Ltd., was approved by Shenzhen Nanshan District People's Government on February 3, 20 10, and was established by Shennanfu (1992)18. 1On July 25th, 1996, Shenzhen Securities Regulatory Bureau approved the reorganization of public joint-stock company with Shenzhen Securities Office's reply (1996) No.68. On April 6th, 1997, Shenzhen Wanghai Bioengineering Co., Ltd. was approved by Shenzhen Administration for Industry and Commerce, with a share capital of 57.3 million yuan.
Tiantan creatures. It is an enterprise engaged in the research, production and management of biological products such as vaccines, blood preparations and diagnostic supplies. Initiated by Beijing Institute of Biological Products, it was listed on the Shanghai Stock Exchange on 1998 (its predecessor was the Central Epidemic Prevention Department of Beiyang Government, and it was established on 19 19, which is the cradle of biological products in China), and its current controlling shareholder is China Biotechnology Group Company. With the development of the company, it now has holding subsidiaries such as Changchun Qijian Biological Products Co., Ltd. and several apheresis plasma companies.
Daan Gene, formerly known as Guangdong Kesida Medical Device Industrial Company, was established with the approval of Guangzhou Administration for Industry and Commerce on August, 2008 1988.
Roper stock. 1October 20th was approved by Qingdao Economic System Reform Commission in document [1997] No.5, and was established by five promoters on the basis of the original Qingdao Oriental Trade Building. With the approval of China Securities Regulatory Commission documents Jian Zheng Fazi [1997] 152 and 153, 30 million RMB ordinary shares were publicly issued to the public, and were listed and circulated in Shenzhen Stock Exchange on May 9, 2007. In February of 2000 1,1,the company reorganized its original assets, and its main business changed fundamentally, that is, it developed from the original commercial retail field to high-tech fields such as medicine and chemical industry. The company held the 2007 annual general meeting of shareholders on May 6, 2008. The meeting reviewed and approved the company's name change (the announcement of the resolution was published in Securities Times on May 17, 2008). Approved by the State Administration for Industry and Commerce, the company name was changed to "Roper Co., Ltd." on May 22, 2008. Upon the application of the company and the approval of Shenzhen Stock Exchange, the short name of the company's securities was changed to "Rope Shares" on May 27th, 2008, and the securities code remained unchanged.